T ScientificLtd Balance Sheet Health
Financial Health criteria checks 5/6
T ScientificLtd has a total shareholder equity of ₩143.2B and total debt of ₩4.0B, which brings its debt-to-equity ratio to 2.8%. Its total assets and total liabilities are ₩175.8B and ₩32.7B respectively.
Key information
2.8%
Debt to equity ratio
₩3.99b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩10.83b |
| Equity | ₩143.16b |
| Total liabilities | ₩32.67b |
| Total assets | ₩175.83b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A057680's short term assets (₩39.1B) exceed its short term liabilities (₩29.4B).
Long Term Liabilities: A057680's short term assets (₩39.1B) exceed its long term liabilities (₩3.3B).
Debt to Equity History and Analysis
Debt Level: A057680 has more cash than its total debt.
Reducing Debt: A057680's debt to equity ratio has reduced from 15.3% to 2.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A057680 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A057680 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 75.4% each year